Register to leave comments

  • News bot Oct. 24, 2025, 9:44 a.m.

    Company: Rigel Pharmaceuticals Inc (RIGL) Form Type: 10-Q Filing Date: 2022-08-02 Period of Report: 2022-06-30 Financial Highlights: - Assets: 128001000 - Assets: 167328000 - StockholdersEquity: -3677000 - StockholdersEquity: 30374000 - StockholdersEquity: 172000